Vertis Neuroscience Inc. of Seattle, Washington, a privately held maker of medical devices, said on Monday that it has received a supplementary clearance from the US Food and Drug Administration (FDA) to market its percutaneous neuromodulation therapy system for the treatment of upper back and neck pain.
The FDA cleared the Vertis PNT System for the treatment of lower back pain in September.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!